Form D · Biotechnology
Genometry, Inc.
Cambridge, MA · CIK 0001558630
Offering snapshot reported Sep 20, 2012 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 30, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2012 | Initial | $3,000,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184406
Source: Form D, filed Sep 20, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Justin Lamb, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Kendall Square Building 200, Suite 3
Cambridge, MA, 02139
Cambridge, MA, 02139